Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease

被引：1

作者：

Andrew K. Evans ^{[1
]}

Heui Hye Park ^{[1
]}

Claire E. Woods ^{[1
]}

Rachel K. Lam ^{[1
]}

Daniel Ryskamp Rijsketic ^{[1
]}

Christine Xu ^{[2
]}

Emily K. Chu ^{[1
]}

Peter Ciari ^{[1
]}

Sarah Blumenfeld ^{[1
]}

Laura M. Vidano ^{[1
]}

Nay Lui Saw ^{[1
]}

Boris D. Heifets ^{[1
]}

Mehrdad Shamloo ^{[2
]}

机构：

[1] Stanford University School of Medicine,Department of Neurosurgery

[2] Stanford University School of Medicine,Department of Anesthesiology, Perioperative, and Pain Medicine

[3] Stanford University School of Medicine,Department of Psychiatry and Behavioral Sciences

来源：

Journal of Neuroinflammation | / 21卷 / 1期

关键词：

Alzheimer’s Disease; Norepinephrine; Locus coeruleus; Beta-adrenergic receptor; Beta-blocker; Neuroinflammation; iDISCO+; Amyloid beta; Microglia;

D O I：

10.1186/s12974-024-03306-1

中图分类号：

学科分类号：

摘要：

Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and it also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in mouse models of Alzheimer’s disease (AD). The current studies were designed to block noradrenergic signaling in 5XFAD mice through (1) chemogenetic inhibition of the locus coeruleus (LC), (2) pharmacologic blocking of β-adrenergic receptors, and (3) conditional deletion of β1- or β2-adrenergic receptors (adrb1 or adrb2) in microglia.

引用

共 50 条

[21] Neuroinflammation in Alzheimer's disease
Zhang, Fengjin
Jiang, Linlan
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 243 - 256
[22] Updates on mouse models of Alzheimer's disease
Zhong, Michael Z.
Peng, Thomas
Duarte, Mariana Lemos
Wang, Minghui
Cai, Dongming
MOLECULAR NEURODEGENERATION, 2024, 19 (01)
[23] Transgenic mouse models for Alzheimer's disease
Moechars, D
Lorent, K
Dewachter, I
Van Leuven, F
NOVEL SYSTEMS FOR THE STUDY OF HUMAN DISEASE: FROM BASIC RESEARCH TO APPLICATIONS, 1998, : 283 - 297
[24] Transgenic mouse models of Alzheimer's disease
Bornemann, KD
Staufenbiel, M
MOLECULAR AND CELLULAR GERONTOLOGY, 2000, 908 : 260 - 266
[25] Transgenic mouse models of Alzheimer's disease
Janus, C
Chishti, MA
Westaway, D
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 63 - 75
[26] Neurogenesis in mouse models of Alzheimer's disease
Chuang, Tsu Tshen
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (10): : 872 - 880
[27] Neuroimaging of Mouse Models of Alzheimer's Disease
Jullienne, Amandine
Trinh, Michelle V.
Obenaus, Andre
BIOMEDICINES, 2022, 10 (02)
[28] Transgenic mouse models of Alzheimer's disease
Sirinathsinghji, DJS
BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (03) : 504 - 508
[29] Updates on mouse models of Alzheimer’s disease
Michael Z. Zhong
Thomas Peng
Mariana Lemos Duarte
Minghui Wang
Dongming Cai
Molecular Neurodegeneration, 19
[30] Transgenic Mouse Models of Alzheimer's Disease
Elder, Gregory A.
Sosa, Miguel A. Gama
De Gasperi, Rita
MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (01): : 69 - 81

← 1 2 3 4 5 →